Brevan Howard Capital Management’s Castle Biosciences CSTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$843K	Buy	41,301 +29,096	+238%	+$594K	﹤0.01%	1056
2025 Q1	$244K	Buy	+12,205	New	+$244K	﹤0.01%	879
2024 Q4	–	Sell	-10,622	Closed	-$303K	–	1077
2024 Q3	$303K	Buy	+10,622	New	+$303K	﹤0.01%	800